Saturday, December 27, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Bitcoin

Strategy Shares Plunge Following Major European Capital Raise

Robert Sasse by Robert Sasse
November 12, 2025
in Bitcoin, Crypto Stocks, Dividends, European Markets
0
Strategy Stock
0
SHARES
123
VIEWS
Share on FacebookShare on Twitter

Strategy, formerly known as MicroStrategy, is facing significant investor skepticism after its stock price dropped more than 6% in the wake of a substantial European financing initiative. The Bitcoin-focused holding company announced a €620 million capital increase through preferred shares issued in Europe, but the market response has been one of disappointment rather than enthusiasm, raising questions about the sustainability of the firm’s aggressive funding strategy.

Financial Strain Evident as Valuation Multiple Contracts

Despite reporting impressive fundamental metrics, Strategy’s market performance tells a different story. The company’s shares have declined approximately 40% over the past six months, with the premium to net asset value collapsing from 2.7 to just 1.06—representing a 20-month low. This erosion in valuation occurs even as the firm reported a third-quarter 2025 net profit of $2.8 billion, substantially exceeding analyst expectations.

The company’s massive Bitcoin holdings now total 640,808 coins, representing over three percent of all Bitcoin ever mined and carrying a market value of approximately $73 billion. With issuing new common stock potentially diluting existing shareholders, CEO Michael Saylor has turned to preferred shares and credit instruments, signaling what some observers interpret as increasing financial pressure.

European Offering Carries High Dividend and Hidden Risks

On November 6, 2025, Strategy successfully placed 7.75 million Series A preferred shares at €80 each, generating net proceeds of roughly €609 million that will be directed toward additional Bitcoin acquisitions. The euro-denominated securities offer investors an attractive 10% annual dividend, payable quarterly with the first distribution scheduled for late December 2025.

Should investors sell immediately? Or is it worth buying Strategy?

However, the offering’s terms reveal potential vulnerabilities. Should dividend payments be deferred, the rate automatically increases—initially to 11%, with a maximum potential climb to 18%. Additionally, investors secured repurchase rights in the event of “fundamental changes” at the company, provisions that suggest Strategy itself may be anticipating potential turbulence ahead.

Bitcoin Dependency Creates Substantial Execution Risk

The company’s ambitious financial targets for 2025—including $34 billion in operating profit and $80 earnings per share—are predicated on Bitcoin reaching $150,000 by year-end. With the cryptocurrency currently trading well below this threshold, Strategy’s entire business model depends on two critical factors: continued appreciation in Bitcoin’s value and investor willingness to fund successive capital raises.

The firm’s annual interest and dividend obligations have now accumulated to $689 million, creating substantial fixed costs that must be serviced regardless of market conditions. Should Bitcoin prices stagnate or decline, this financial structure could face significant stress.

Despite these concerns, analyst sentiment remains predominantly positive. Twelve out of fifteen covering analysts maintain “Strong Buy” recommendations, with an average price target of $523 representing more than a 100% potential increase from current trading levels.

Ad

Strategy Stock: Buy or Sell?! New Strategy Analysis from December 27 delivers the answer:

The latest Strategy figures speak for themselves: Urgent action needed for Strategy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 27.

Strategy: Buy or sell? Read more here...

Tags: Strategy
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Novo Nordisk Stock
Analysis

Novo Nordisk Shares Signal a Turnaround with Key FDA Approval

December 27, 2025
Realty Income Stock
Analysis

Realty Income Shares Pause Near Peak Levels

December 27, 2025
Diginex Stock
Analysis

Diginex Shares Under Pressure as Investor Confidence Wanes

December 26, 2025
Next Post
Broadcom Stock

Broadcom Shares Show Signs of Consolidation Amid Market Gains

Microsoft Stock

Microsoft's European AI Expansion Gains Momentum with Major Portuguese Investment

Cardano Stock

Major Cardano Investors Signal Confidence with Massive Accumulation

Recommended

QuantumScape Stock

QuantumScape Leadership Exodus Sparks Investor Concerns

1 month ago
Clean Energy Fuels Stock

Clean Energy Fuels Navigates a Mixed Outlook in the Renewable Gas Sector

4 months ago
Tempus AI Stock

Tempus AI: Market Experts Divided as Healthcare Innovator Posts First Profit

2 months ago
Omnicell Stock

Omnicell Shares Face Persistent Selling Pressure Despite Solid Earnings

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Novo Nordisk Shares Signal a Turnaround with Key FDA Approval

Rocket Lab Shares Pull Back Following Record Rally

Institutional Buyers See Opportunity in PepsiCo’s Recent Stock Weakness

Realty Income Shares Pause Near Peak Levels

Broadcom’s Margin Outlook Overshadows Record AI Revenue

Tesla’s AI Ambitions Face Reality Check Amid Operational Hurdles

Trending

AMD Stock
AI & Quantum Computing

AMD’s Billion-Dollar China Opportunity Meets Investor Caution

by Robert Sasse
December 27, 2025
0

Advanced Micro Devices (AMD) is navigating a complex landscape of significant opportunity and growing market skepticism. The...

Adobe Stock

Adobe Stock: Diverging Views Highlight Strategic Crossroads

December 27, 2025
Intel Stock

Intel’s Remarkable Resurgence: A Critical Juncture in 2025

December 27, 2025
Novo Nordisk Stock

Novo Nordisk Shares Signal a Turnaround with Key FDA Approval

December 27, 2025
Rocket Lab USA Stock

Rocket Lab Shares Pull Back Following Record Rally

December 27, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • AMD’s Billion-Dollar China Opportunity Meets Investor Caution
  • Adobe Stock: Diverging Views Highlight Strategic Crossroads
  • Intel’s Remarkable Resurgence: A Critical Juncture in 2025

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com